rose bengal disodium

Small molecule

Phase 3Mechanism not establishedNo recent registered activity
Stoppedregistry status

Evidence outlook

Phase 3 study terminated, no active studies registered

The furthest-phase study registered for this program (NCT02288897) was terminated, and no study is currently active on the registry. No evidence signal is assigned from a stopped study. Check the registry record for the sponsor's stated reason.

Featured evidence outside this drug's tracked markets:NCT00237354 · Breast Cancer · Phase 1 · completed · ungraded

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.

Phase 3 (1)
Locally Advanced Cutaneous Melanoma
Phase 2 (2)
Other / comorbidity
NCT00521053 · Provectus Pharmaceuticals
2007-09 – 2012-06 · Melanoma
What this study did
NCT00555646 · Provectus Pharmaceuticals
2007-11 – 2008-09 · Plaque Psoriasis
What this study did
Phase 1/2 (1)
Other / comorbidity
Phase 1 (5)
Other / comorbidity
NCT02693067 · Provectus Biopharmaceuticals, Inc.
2016-07 – 2023-09 · Neuroendocrine Tumors Metastatic to the Liver
What this study did
NCT00986661 · Provectus Biopharmaceuticals, Inc.
2009-10 – 2023-02 · Cancer Metastatic to the Liver, Hepatocellular Carcinoma, Metastatic Melanoma, Metastatic Ocular Melanoma, Metastatic Uveal Melanoma, Metastatic Lung Cancer, Metastatic Colon Cancer, Metastatic Colorectal Cancer, Metastatic Breast Cancer, Metastatic Pancreatic Cancer
What this study did
NCT01760499 · H. Lee Moffitt Cancer Center and Research Institute
2013-01-24 – 2017-04 · Melanoma
What this study did
NCT00237354 · Provectus Pharmaceuticals
2005-10 – 2008-07 · Breast Cancer
What this study did
NCT00219843 · Provectus Pharmaceuticals
2005-08 – 2007-08 · Melanoma
What this study did

Competitive landscape

No competitors sharing a mechanism or indication in the current universe.

Upcoming events

No upcoming readouts on record for this asset.